Unparalleled Psychedelic Investing Data and Analysis
Psychedelic Invest is a resource for those looking to invest in the burgeoning psychedelic industry.
PsyBio Therapeutics Corp. announced that the company will commence trading on the TSX Venture Exchange under the ticker symbol “PSYB”.
PharmaDrug Inc. announced it has expanded its psychedelic pharmaceutical program with the filing of an application with the U.S. Food and Drug Administration.
NeonMind Biosciences Inc. announced that it has purchased an initial order of GMP grade psilocybin from Psygen Labs Inc.
PharmaTher Announces Research Collaboration for Novel Microneedle Delivery of Psychedelic Pharmaceuticals
PharmaTher Inc. announced that they have entered into a sponsored research agreement with the Terasaki Institute to develop a novel microneedle patch that aims to deliver psychedelic pharmaceuticals.
Awakn Chief Medical Officer Announces Results of the World’s First ‘MDMA in Alcohol Use Disorder’ Trial
Awakn Life Sciences Inc. announced the publication of results from its CMO Dr. Ben Sessa’s Bristol Imperial MDMA in Alcoholism (BIMA) trial.
Bionomics (BNO), an Australian listed clinical stage biopharmaceutical company announced on Wednesday that it has partnered with EmpathBio, a subsidiary of the largest private psychedelic company, ATAI Life Sciences. Through the new partnership, the companies will explore a combination drug treatment regimen using EmpathBio’s MDMA derivative, EMP-01, and Bionomics’ lead drug candidate, BNC210. The regimen […]
Mindset Pharma Inc. announced that it has been added to the North American Psychedelics Index.
Explore the Psychedelic Landscape
Learn more about the psychedelic companies changing the industry.